Oxford Immunotec Schedules First Quarter 2020 Earnings Release and Conference Call for May 5, 2020

Udgivet den 29-04-2020  |  kl. 13:15  |  

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2020 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the Company), a global, high-growth diagnostics company, today announced that it plans to release first quarter 2020 financial results before the open of the market on Tuesday, May 5, 2020.  Dr. Peter Wrighton-Smith, Chief Executive Officer, and Matt McLaughlin, Chief Financial Officer, will host a conference call to review the Company's financial results at 8:00 a.m. Eastern Time the same day.  The call will be concurrently webcast.

To listen to the conference call on your telephone, please dial (855) 363-5047 for United States callers or +1 (484) 365-2897 for international callers and reference confirmation code 8473556, approximately 15 minutes prior to start time.  To access the live audio webcast or subsequent archived recording, visit the Investor Relations section of Oxford Immunotec's website at www.oxfordimmunotec.com.  The replay will be available on the Company's website for approximately 60 days.

About Oxford Immunotec

Oxford Immunotec Global PLC is a global, high-growth diagnostics company.  We bring energy and invention to a world in need of diagnostic truth.  Our leading product, the T-SPOT®.TB test, is used for diagnosing infection with Tuberculosis, the world's largest cause of death from infectious disease.  The T-SPOT.TB test has been approved for sale in over 60 countries, including the United States, where it has received pre-market approval from the Food and Drug Administration, Europe, where it has obtained a CE mark, as well as Japan and China.  The Company is headquartered near Oxford, U.K. and in Marlborough, MA.  Additional information can be found at www.oxfordimmunotec.com.

T-SPOT and the Oxford Immunotec logo are trademarks of Oxford Immunotec Ltd.

CONTACTS:

For Media and Investor Inquiries:
Matt McLaughlin
Chief Financial Officer
Oxford Immunotec
Tel: +1 (508) 573-9953
mtmclaughlin@oxfordimmunotec.com

\Hugin

Udgivet af: NPinvestordk

Seneste nyheder

12:01 Moncler stiger på frisk købsanbefaling fra Goldman Sachs
11:53 Aktier/middag: Bryggeriaktier i top på afventende dag - Mærsk i mindre dyk trods ratetal
11:16 Danske Bank om næste uges rentemøde i ECB: Stor rentenedsættelse kan komme på tale
09:32 Britisk forsikringsselskab stiger over 7 pct. efter købstilbud fra rival
09:14 Aktier/åbning: Vestas stiger i morgensurt C25 trods negativ analyse
08:52 Obligationer/åbning: Renten siver let inden eftermiddagens jobrapport
08:43 Den danske industriproduktion steg i oktober
08:17 Aktier/tendens: Voldsom trængsel og alarm hos analysehusene inden jobrapport fra USA
08:09 Mærsk kan glæde sig over anden uge i træk med ratefremgang
08:03 Novo-rival annoncerer investering på et tocifret milliardbeløb i fabriksudvidelse
07:45 Råvarer: Oliepriserne falder på udskydelse af produktionsstigninger
06:58 Obligationer/tendens: Rentefald i vente inden spænding omkring jobrapporten udløses
06:39 Asien: Generelle fald på usikkerhed om politisk udvikling
06:35 Opec+ går efter langsommere genrejsning af produktionen
06:35 Ørsted får skåret sin anbefaling af amerikansk storbank
06:34 Mærsks asiatiske konkurrenter viser blandede takter fredag
06:34 FLSmidth får indledt dækning hos Barclays med anbefalingen "undervægt"
06:32 Asien: Generelle fald på usikkerhed om politisk udvikling
06:32 Valuta: Øretæver til kryptofans mens det bredere valutamarked puster ud
06:32 USA/T-bond: Renterne stod stille mens investorerne afventede vigtig jobrapport